Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Exclusion Criteria

• •Patient must not
• •Have taken any pain medication including nonsteroidal anti-inflammatory drugs (NSAIDs) within 2 weeks prior to study injection date.
• •Use anticoagulants have a substance abuse history, and fail to agree not to take any lumbar symptom modifying drugs during the course of the study without discussing and reporting the use to the site Clinical investigator and study team.
• •Known allergy to penicillin, sulfa or amphotericin medications.
• •Have had any lumbar injections (at all) of any drug in lumbar spine in the past 6 months.
• •Have had surgery on the lumbar spine within the past 6 months.
• •Had a traumatic injury to the lumbar spine with the past 3 months.
• •Planned elective surgery during the course of the study.
• •A history of organ or hematologic transplantation, rheumatoid arthritis, or other autoimmune disorders.
• •Be on immunosuppressive medications.
• •Have a diagnosis of carcinoma with the past 5 years.
• •Have a lumbar infection or have used antibiotics for lumbar infection within the past 3 months.
• •Have participated in any other clinical study or treatment (not just for the lumbar spine, but for any reason) with any investigational product within the past 30 days prior to inclusion of study.
• •Female participants who are breast feeding or are pregnant or desire to become pregnant during the course of the study.
• •Contraindications to radiographic or MRI imaging.
• •Serious neurological, psychological or psychiatric disorders.
• •Injury or disability claims under current litigation or pending or approved workers compensation claims.